DERM
Journey Medical Corp
6.30$
-2.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 18.6% | 39.4% | 52.3% | 44.0% | 36.1% | 16.4% | 44.6% | 40.0% | 32.6% | 40.5% | 46.0% | 33.2% | 37.8% | |
| 81.4% | 60.6% | 47.7% | 56.0% | 63.9% | 83.6% | 55.4% | 60.0% | 67.4% | 59.5% | 54.0% | 66.8% | 62.2% | |
| 6.5% | 9.9% | 60.5% | 6.1% | 5.8% | 1.6% | 0.3% | 0.0% | 1.6% | 1.0% | 0.0% | 0.3% | 0.7% | |
| 25.0% | 79.6% | 64.6% | 69.5% | 77.9% | 73.9% | 80.4% | 79.2% | 68.4% | 61.3% | 63.3% | 58.8% | 62.9% | |
| 31.5% | 74.4% | 125.1% | 75.7% | 83.7% | 67.2% | 80.7% | 79.2% | 76.0% | 62.3% | 63.3% | 64.3% | 66.6% | |
| 49.9% | -13.8% | -77.4% | -19.7% | -19.8% | 16.4% | -25.3% | -19.2% | -8.7% | -2.8% | -9.3% | 2.5% | -4.4% | |
| 0.8% | 0.2% | 4.2% | 3.8% | 5.2% | 6.1% | 6.8% | 6.2% | 5.3% | 5.8% | 5.6% | 4.9% | 5.4% | |
| 48.9% | -13.2% | -80.1% | -22.6% | -16.3% | 11.6% | -31.0% | -24.9% | -13.1% | -7.8% | -14.0% | -1.6% | -8.9% | |
| 0.3% | 0.8% | 6.1% | – | – | 0.4% | – | 0.4% | – | – | – | 0.1% | – | |
| 48.6% | -14.0% | -80.1% | -22.6% | -16.3% | 11.2% | -31.0% | -25.3% | -13.1% | -7.8% | -14.0% | -1.7% | -9.0% | |
| 52.1% | -7.6% | -69.5% | -13.2% | -5.4% | 25.1% | -16.0% | -11.4% | -1.8% | 4.8% | -1.2% | 8.5% | 2.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.